This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Kristine McKinney, PhD
Vice President and Head, Cancer Vaccines Research at Moderna
Speaker

Profile

Kristine McKinney, Ph.D., is Vice President and Head of Cancer Vaccines and Bioinformatics Research at Moderna, where she leads a multidisciplinary team advancing mRNA-based therapeutic cancer vaccines. She oversees research and discovery in therapeutic cancer vaccines and supports programs as they progress through clinical development, bringing deep expertise in discovery biology, immunology, and bioinformatics to expand therapeutic possibilities for patients with cancer.

She has held multiple leadership roles at Moderna, advancing novel applications of the mRNA-LNP platform across oncology, immuno-oncology, and gene editing. Dr. McKinney earned her Ph.D. from Columbia University and completed postdoctoral training at Dana-Farber Cancer Institute.

Agenda Sessions

  • Expanding the Impact of mRNA Cancer Therapeutics

    2:00pm